Nephron 2020 Jan 31
Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ
The impact of pretransplant donor-specific antibodies (DSAs), especially class II DSAs, on kidney allograft outcomes remains unclear in simultaneous l ...
Read More
Source: PubMed
J. Am. Coll. Surg. 2020 Jan 30
Difference in Survival in Early Kidney after Liver Transplant Compared with Simultaneous Liver-Kidney Transplantation: Evaluating the Potential of the "Safety Net".
Jay CL, Washburn WK, Rogers J, Harriman D, Heimbach J, Stratta RJ
Decisions on who requires simultaneous liver-kidney (SLK) transplantation are controversial. United Network for Organ Sharing implemented a "safety ne ...
Read More
Source: PubMed
J. Am. Coll. Surg. 2020 Jan 30
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception.
Cannon RM, Davis EG, Goldberg DS, Lynch RJ, Shah MB, Locke JE, McMasters KM, Jones CM
Patients thought to be at greater risk of liver waitlist dropout than their laboratory MELD (lMELD) score reflects are commonly given MELD exceptions, ...
Read More
Source: PubMed
HPB (Oxford) 2020 Jan 29
Effect of remote ischemic preConditioning on liver injury in patients undergoing liver resection: the ERIC-LIVER trial.
Teo JY, Ho AFW, Bulluck H, Gao F, Chong J, Koh YX, Tan EK, Abdul Latiff JB, Chua SH, Goh BKP, Chan CY, Chung AYF, Lee SY, Cheow PC, Ooi LLPJ, Davidson BR, Jevaraj PR, Hausenloy DJ
Novel hepatoprotective strategies are needed to improve clinical outcomes during liver surgery. There is mixed data on the role of remote ischemic pre ...
Read More
Source: PubMed
G Chir
Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.
Damaskos C, Kaskantamis A, Garmpis N, Dimitroulis D, Mantas D, Garmpi A, Sakellariou S, Angelou A, Syllaios A, Kostakis A, Lampadariou E, Floros I, Revenas K, Antoniou EA
Orthotopic Liver Transplantation (OLT) is the treatment of choice for patients with end stage liver disease, acute liver failure, hepatocellular carci ...
Read More
Source: PubMed
Nephron 2020 Jan 31
Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ
The impact of pretransplant donor-specific antibodies (DSAs), especially class II DSAs, on kidney allograft outcomes remains unclear in simultaneous l ...
Read More
Source: PubMed
J. Am. Coll. Surg. 2020 Jan 30
Difference in Survival in Early Kidney after Liver Transplant Compared with Simultaneous Liver-Kidney Transplantation: Evaluating the Potential of the "Safety Net".
Jay CL, Washburn WK, Rogers J, Harriman D, Heimbach J, Stratta RJ
Decisions on who requires simultaneous liver-kidney (SLK) transplantation are controversial. United Network for Organ Sharing implemented a "safety ne ...
Read More
Source: PubMed
J. Am. Coll. Surg. 2020 Jan 30
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception.
Cannon RM, Davis EG, Goldberg DS, Lynch RJ, Shah MB, Locke JE, McMasters KM, Jones CM
Patients thought to be at greater risk of liver waitlist dropout than their laboratory MELD (lMELD) score reflects are commonly given MELD exceptions, ...
Read More
Source: PubMed
HPB (Oxford) 2020 Jan 29
Effect of remote ischemic preConditioning on liver injury in patients undergoing liver resection: the ERIC-LIVER trial.
Teo JY, Ho AFW, Bulluck H, Gao F, Chong J, Koh YX, Tan EK, Abdul Latiff JB, Chua SH, Goh BKP, Chan CY, Chung AYF, Lee SY, Cheow PC, Ooi LLPJ, Davidson BR, Jevaraj PR, Hausenloy DJ
Novel hepatoprotective strategies are needed to improve clinical outcomes during liver surgery. There is mixed data on the role of remote ischemic pre ...
Read More
Source: PubMed
G Chir
Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.
Damaskos C, Kaskantamis A, Garmpis N, Dimitroulis D, Mantas D, Garmpi A, Sakellariou S, Angelou A, Syllaios A, Kostakis A, Lampadariou E, Floros I, Revenas K, Antoniou EA
Orthotopic Liver Transplantation (OLT) is the treatment of choice for patients with end stage liver disease, acute liver failure, hepatocellular carci ...
Read More
Source: PubMed
